Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2026-02-24 @ 5:08 AM
Study NCT ID:
NCT05737303
Status:
RECRUITING
Last Update Posted:
2025-02-11
First Post:
2023-01-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer
Sponsor:
Women's Hospital School Of Medicine Zhejiang University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Epithelial Ovarian Carcinoma Stage III | View |
| None | Epithelial Ovarian Carcinoma Stage IV | View |
| None | Fallopian Tube Carcinoma Stage III | View |
| None | Fallopian Tube Carcinoma Stage IV | View |
| None | Primary Peritoneal Carcinoma Stage III | View |
| None | Primary Peritoneal Carcinoma Stage IV | View |
Keywords: